CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (Apo-2L) in haematological malignancies.
Fiumara
P
P
Department of Lymphoma and Myeloma, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.
Younes
A
A
D017209:Apoptosis / Q000276:immunology; D051017:Apoptosis Regulatory Proteins; D001402:B-Lymphocytes / Q000276:immunology; D019013:CD40 Antigens / Q000276:immunology; D023201:CD40 Ligand / Q000276:immunology*; D019337:Hematologic Neoplasms / Q000276:immunology*; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D016393:Lymphoma, B-Cell / Q000276:immunology; D016399:Lymphoma, T-Cell / Q000276:immunology; D008562:Membrane Glycoproteins / Q000276:immunology*; D016539:Reed-Sternberg Cells / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D053221:TNF-Related Apoptosis-Inducing Ligand; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology*
D051017:Apoptosis Regulatory Proteins; D019013:CD40 Antigens; D008562:Membrane Glycoproteins; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human; D014409:Tumor Necrosis Factor-alpha; D023201:CD40 Ligand